Pressure Bio (PBIO) Stock Price, News & Analysis
Company Description
Pressure Bio (OTC Link: PBIO) is classified in the medical devices industry within the Healthcare sector and carries a market capitalization of $4.1K.
PBIO has gained 300.0% over the past year. Shares last traded at $0.0004.
This page collects what Stock Titan holds for PBIO, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Pressure Bio (PBIO) stock last closed at $0.0004. Over the past 12 months, the stock has gained 300.0%. At a market capitalization of $4.1K, PBIO is classified as a micro-cap stock with approximately 41.0M shares outstanding.
Latest News
Pressure Bio has 10 recent news articles. Of the recent coverage, 4 articles coincided with positive price movement and 6 with negative movement. Key topics include partnership, conferences, acquisition. View all PBIO news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Short interest in Pressure Bio (PBIO) currently stands at 13 shares.
Days to Cover History
Days to cover for Pressure Bio (PBIO) currently stands at 1.0 days. This low days-to-cover ratio indicates high liquidity, allowing short sellers to quickly exit positions if needed.
PBIO Company Profile & Sector Positioning
Pressure Bio (PBIO) operates in the Medical Devices industry within the broader Healthcare sector and is listed on the OTC Link.
Investors comparing PBIO often look at related companies in the same sector, including Nemaura Med Inc (NMRD), TRANSLATE BIO, INC. (TBIO), Opgen (OPGN), Motus Gi Hldgs Inc (MOTS), and Guided Thera (GTHP). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate PBIO's relative position within its industry.